Postpartum Hemorrhage (Excessive Bleeding After Parturition)

Postpartum hemorrhage (PPH) is a potentially life-threatening obstetric emergency characterized by excessive bleeding from the reproductive tract within 24 to 72 hours after parturition, though it can occur up to several days postpartum. In veterinary theriogenology, PPH is less common than in human medicine but carries high maternal morbidity and mortality if not promptly recognized and managed. The condition results from failure of uterine hemostasis, which normally involves myometrial contraction, vascular constriction, and local coagulation. In bitches and queens, PPH is often associated with uterine inertia, retained fetal membranes, uterine trauma, or coagulopathies. The clinical spectrum ranges from mild, self-limiting hemorrhage to severe, exsanguinating blood loss leading to hypovolemic shock, disseminated intravascular coagulation (DIC), and death. Accurate diagnosis requires a thorough understanding of normal postpartum involution, which involves uterine contraction, lochial discharge (which is normally dark green to brown in dogs due to uteroverdin), and gradual reduction in uterine size over 4-6 weeks. PPH must be distinguished from normal lochia, which is typically non-clotting and diminishes over time. The condition is classified as primary (immediate, within 24 hours) or secondary (delayed, 24 hours to 6 weeks), and as local (uterine, vaginal, vulvar) or systemic (coagulopathy). Prompt intervention is critical to preserve fertility and save the dam's life.

The etiologies of postpartum hemorrhage are multifactorial. Primary causes include uterine inertia (primary or secondary), which prevents effective myometrial contraction and hemostasis; retained fetal membranes or placental fragments, which interfere with uterine involution and cause continued bleeding; uterine trauma or rupture during a difficult parturition (dystocia) or obstetric manipulation; and vaginal or vulvar lacerations from fetal passage or episiotomy. Coagulopathies, either inherited (e.g., von Willebrand disease, hemophilia) or acquired (e.g., DIC secondary to placental site infection or retained fetus), can precipitate severe hemorrhage. In addition, uterine subinvolution of placental sites (USPS) is a specific condition in bitches where the placental attachment sites fail to involute properly, leading to persistent bleeding for weeks postpartum. Infectious agents, such as Brucella canis, Escherichia coli, or Streptococcus spp., can cause endometritis or metritis, weakening uterine blood vessels and promoting hemorrhage. Hormonal imbalances, particularly relative hyperestrogenism or progesterone withdrawal, may impair uterine contractility. Iatrogenic causes include excessive traction during fetal extraction, improper use of oxytocin (leading to uterine tetany and rupture), or cesarean section complications. Neoplastic conditions, such as uterine leiomyoma or vaginal tumors, are rare but can bleed postpartum. Finally, environmental stress, poor nutrition, and hypocalcemia can contribute to uterine inertia and subsequent hemorrhage.

Postpartum hemorrhage is relatively uncommon in small animal practice, with reported incidence rates of 1-5% in bitches and queens, though exact figures are lacking. It is more frequently observed in certain breeds: brachycephalic breeds (e.g., Bulldogs, Boston Terriers) and toy breeds (e.g., Chihuahuas, Yorkshire Terriers) are predisposed to dystocia and uterine inertia, increasing the risk of PPH. Primiparous females are at higher risk due to prolonged labor and uterine fatigue. Older females, particularly those over 6 years of age, may have uterine fibrosis or concurrent uterine pathology (e.g., cystic endometrial hyperplasia) that impairs involution. The condition is more common in bitches than queens, likely due to the higher incidence of dystocia in dogs. In cats, PPH is often associated with uterine trauma during difficult deliveries, especially in breeds with large fetal heads (e.g., Persians). Females with a history of previous dystocia, cesarean section, or uterine surgery are at increased risk. Additionally, females with inherited coagulopathies, such as von Willebrand disease (common in Doberman Pinschers, Scottish Terriers, and Shetland Sheepdogs), are more susceptible. Poor breeding management, including improper timing of mating, inadequate nutrition during pregnancy, and lack of veterinary supervision during whelping, contributes to the incidence. In kennel or cattery environments, stress and overcrowding may exacerbate the risk. Overall, PPH is a sporadic but serious emergency that requires immediate attention.

The pathophysiology of postpartum hemorrhage involves a complex interplay of uterine involution, hemostasis, and tissue repair. Normally, after expulsion of the fetus and placenta, the uterus contracts rapidly, compressing the spiral arteries and veins that supplied the placental site. This mechanical hemostasis is reinforced by local coagulation and subsequent thrombosis. The myometrium undergoes rhythmic contractions, which are stimulated by oxytocin released from the posterior pituitary in response to cervical and vaginal distension. In PPH, failure of these mechanisms leads to continued bleeding. Uterine inertia, often due to hypocalcemia, uterine overdistension, or exhaustion of oxytocin receptors, prevents effective contraction. Retained placental fragments act as foreign bodies, preventing uterine involution and maintaining blood flow to the placental site. In subinvolution of placental sites (USPS), the normal process of endometrial regeneration is delayed, and the blood vessels at the former placental attachment remain dilated and fragile, leading to chronic hemorrhage. Trauma to the birth canal, such as vaginal lacerations or uterine rupture, directly damages blood vessels, causing active bleeding. Coagulopathies, whether inherited or acquired, impair the formation of stable clots, exacerbating any bleeding tendency. DIC can develop as a consequence of massive hemorrhage, tissue necrosis, or sepsis, leading to consumption of clotting factors and further bleeding. Endometritis or metritis, often due to bacterial infection, causes inflammation and weakening of the uterine vasculature. The clinical signs of PPH are directly related to the volume and rate of blood loss, ranging from mild anemia to hypovolemic shock, with compensatory tachycardia, pale mucous membranes, and poor peripheral perfusion. If untreated, the condition can progress to cardiovascular collapse, multiple organ failure, and death.

Predisposing factors for postpartum hemorrhage can be intrinsic or extrinsic. Intrinsic factors include breed predisposition (brachycephalic and toy breeds), age (very young or old dams), parity (primiparous or grand multiparous), and genetic coagulopathies (e.g., von Willebrand disease, hemophilia). Hormonal imbalances, such as hypocalcemia (which impairs myometrial contractility) or hyperestrogenism (which may cause uterine atony), are significant. Uterine abnormalities, including uterine inertia, uterine torsion, or uterine rupture, predispose to hemorrhage. Retained fetal membranes or placental fragments are common predisposing factors. Concurrent uterine infections (metritis) or systemic infections can weaken blood vessels. Extrinsic factors include poor nutrition during pregnancy, leading to hypocalcemia or anemia; excessive or improper obstetric manipulation during dystocia, causing trauma; and iatrogenic factors such as excessive oxytocin administration, which can cause uterine tetany and rupture. Environmental stress, such as overcrowding, noise, or transportation, can inhibit normal uterine contractions. In addition, a history of previous cesarean section or uterine surgery may leave scar tissue that is less contractile. Finally, inadequate veterinary supervision during parturition, leading to delayed intervention in cases of dystocia, increases the risk of trauma and hemorrhage.

Clinical signs of postpartum hemorrhage vary depending on the severity and underlying cause. The most obvious sign is persistent, excessive vaginal bleeding, which may be bright red (active arterial bleeding) or dark red with clots (venous or uterine bleeding). The discharge may be continuous or intermittent, and the dam may show signs of straining or licking the vulva. In mild cases, the dam may appear otherwise normal, but in severe cases, signs of hypovolemic shock develop: lethargy, weakness, pale mucous membranes, tachycardia, tachypnea, cold extremities, and prolonged capillary refill time (>2 seconds). The dam may collapse or become recumbent. Abdominal distension may be present if there is intra-abdominal hemorrhage from uterine rupture. On abdominal palpation, the uterus may be enlarged and doughy, and pain may be elicited. The dam may show signs of restlessness, anxiety, or aggression due to pain. In cases of retained placenta or metritis, there may be a foul-smelling vaginal discharge, fever, and signs of systemic illness. In chronic cases (e.g., subinvolution of placental sites), bleeding may persist for weeks, leading to progressive anemia, weight loss, and poor maternal condition. In queens, similar signs are observed, but they may be more subtle. It is important to differentiate normal lochia (which is dark green to brown, non-clotting, and gradually decreases over 2-3 weeks) from pathological hemorrhage.

Differential diagnoses for postpartum hemorrhage include: 1) Normal postpartum lochia: This is typically dark green to brown, non-clotting, and decreases over time; it does not cause systemic signs. 2) Retained fetal membranes or placenta: May cause persistent bleeding and a foul odor; ultrasonography may show echogenic material within the uterus. 3) Uterine subinvolution of placental sites (USPS): Characterized by prolonged, often intermittent, bleeding for weeks; diagnosis is by exclusion and ultrasonography showing irregular uterine wall. 4) Metritis or endometritis: Associated with fever, lethargy, and purulent, malodorous discharge; systemic signs are more prominent. 5) Uterine rupture: Causes acute abdominal pain, shock, and possibly hemoperitoneum; ultrasonography may show free fluid and uterine discontinuity. 6) Vaginal or vulvar lacerations: Bleeding may be localized and visible on examination; often associated with trauma during parturition. 7) Coagulopathies (e.g., von Willebrand disease, DIC): May present with bleeding from multiple sites, petechiae, and abnormal clotting times. 8) Uterine neoplasia (rare): May cause chronic bleeding; imaging and biopsy are needed. 9) Trauma to the reproductive tract from obstetric manipulation: History of difficult delivery or intervention. 10) Eclampsia (hypocalcemia): May cause restlessness, tremors, and seizures, but not typically hemorrhage; however, it can predispose to uterine inertia and secondary hemorrhage.

The diagnostic approach to postpartum hemorrhage should be systematic and rapid. Step 1: Perform a thorough physical examination, including assessment of vital signs (heart rate, respiratory rate, temperature, mucous membrane color, capillary refill time) and abdominal palpation. Step 2: Obtain a detailed history, including parity, duration of labor, any obstetric interventions, and onset and character of bleeding. Step 3: Assess the vaginal discharge: note color, volume, presence of clots, and odor. Step 4: Perform a vaginal examination (with sterile gloves and lubricant) to identify lacerations, retained fetal membranes, or foreign bodies. Step 5: Collect blood samples for complete blood count (CBC), serum biochemistry (including calcium, glucose, liver enzymes), and coagulation profile (PT, aPTT, fibrinogen, D-dimer). Step 6: Perform abdominal ultrasonography to evaluate the uterus: assess size, wall thickness, echogenicity of contents, presence of fetal remnants, and free abdominal fluid. Also, evaluate the ovaries for corpora lutea. Step 7: If coagulopathy is suspected, perform specific tests such as von Willebrand factor assay or blood smear for schistocytes. Step 8: In cases of suspected infection, collect a vaginal swab for cytology and culture. Step 9: If uterine rupture is suspected, perform abdominal radiography or computed tomography (CT) to detect free gas or fluid. Step 10: In stable patients, consider vaginoscopy to visualize the vaginal vault and cervix. The diagnostic algorithm should be adapted based on the patient's stability; in unstable patients, immediate stabilization and surgical exploration may be necessary without extensive diagnostics.

Laboratory findings in postpartum hemorrhage depend on the severity and chronicity of blood loss. In acute hemorrhage, the CBC may initially show a normal or elevated packed cell volume (PCV) due to splenic contraction, but within hours, PCV and hemoglobin decrease as hemodilution occurs. There may be thrombocytopenia if there is consumption of platelets. In chronic cases, anemia is evident with decreased PCV, hemoglobin, and red blood cell count. Leukocytosis with a left shift may be present if there is concurrent metritis or tissue necrosis. Serum biochemistry may reveal hypocalcemia (total calcium < 8.5 mg/dL), which can contribute to uterine inertia; hypoglycemia may occur due to stress or sepsis. Liver enzymes (ALT, AST) may be elevated if there is hepatic hypoxia or DIC. Blood urea nitrogen (BUN) and creatinine may be elevated due to prerenal azotemia from hypovolemia. Coagulation profile may show prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), decreased fibrinogen, and elevated D-dimer, indicating DIC. Vaginal cytology may show red blood cells, neutrophils, and bacteria; the presence of intracellular bacteria suggests metritis. Uterine culture may grow pathogens such as E. coli, Streptococcus spp., or Staphylococcus spp. In cases of USPS, cytology may show large, foamy macrophages containing hemosiderin. Hormonal assays may be useful: serum progesterone should be low (< 1 ng/mL) after normal parturition; elevated progesterone may indicate retained placental tissue or ovarian remnant. Prolactin levels may be elevated during lactation. Overall, laboratory findings help assess the severity of hemorrhage, identify underlying causes, and guide treatment.

Imaging plays a crucial role in the diagnosis and management of postpartum hemorrhage. Abdominal ultrasonography is the primary imaging modality. In normal postpartum bitches, the uterus is located in the caudal abdomen, and its diameter decreases progressively over 4-6 weeks. In PPH, the uterus may be enlarged, with a thickened, irregular wall. The uterine lumen may contain echogenic fluid or debris, which could represent blood clots, retained placental fragments, or fetal membranes. Color Doppler ultrasonography can assess blood flow to the uterine wall; increased vascularity may indicate subinvolution or inflammation. Free abdominal fluid (anechoic or echogenic) suggests uterine rupture or hemoperitoneum. Ultrasonography can also identify retained fetuses or fetal bones. In cases of USPS, the uterine wall may show focal hypoechoic areas at the former placental sites. Radiography is less sensitive but can detect fetal remnants (mineralized bones) or free abdominal gas in cases of uterine rupture. Computed tomography (CT) and magnetic resonance imaging (MRI) are rarely used but can provide detailed assessment of uterine integrity and vascularity. Vaginoscopy can directly visualize vaginal lacerations or retained fetal membranes. In cases of suspected coagulopathy, imaging of other organs (e.g., thorax) may be indicated to rule out bleeding into body cavities. Overall, ultrasonography is the most valuable imaging tool, as it is non-invasive, readily available, and provides real-time information.

Cytological and histopathological evaluation is essential for diagnosing the underlying cause of postpartum hemorrhage. Vaginal cytology can be performed by collecting a swab from the cranial vagina. In normal postpartum, cytology shows red blood cells, neutrophils, and occasional epithelial cells. In PPH, there may be a large number of red blood cells, and the presence of hemosiderin-laden macrophages suggests chronic hemorrhage. Neutrophils with intracellular bacteria indicate metritis. Histopathology of uterine biopsies or tissue removed during ovariohysterectomy can reveal the specific pathology. In subinvolution of placental sites, histopathology shows dilated, thick-walled blood vessels at the former placental attachment sites, with incomplete endometrial regeneration and infiltration of inflammatory cells. In metritis, there is diffuse infiltration of neutrophils and bacteria within the endometrium and myometrium. In uterine rupture, there is disruption of the uterine wall with hemorrhage and necrosis. In cases of coagulopathy, histopathology may show evidence of DIC, such as microthrombi in small vessels. If a neoplastic process is suspected, histopathology can identify the tumor type and grade. Special stains, such as Gram stain for bacteria or Masson's trichrome for fibrosis, may be helpful. Cytology of abdominal fluid, if present, may show red blood cells and inflammatory cells, supporting hemoperitoneum or peritonitis. Overall, cytology and histopathology provide definitive diagnoses and guide targeted therapy.

Treatment of postpartum hemorrhage must be prompt and aggressive, focusing on stabilization, control of bleeding, and correction of underlying causes. The first step is to assess and stabilize the dam: establish intravenous access, administer crystalloid fluids (e.g., Lactated Ringer's solution) at shock rates (e.g., 90 mL/kg in dogs, 60 mL/kg in cats) to restore perfusion, and provide oxygen supplementation if needed. Blood transfusion may be necessary if PCV drops below 20% or if there is ongoing severe hemorrhage. Pharmacological management includes: 1) Oxytocin: 0.5-2 IU/kg IM or IV (dogs) and 0.5-1 IU/kg IM (cats) to promote uterine contraction; can be repeated every 30 minutes, but avoid in cases of uterine rupture or obstruction. 2) Calcium gluconate: 10% solution, 0.5-1.5 mL/kg IV slowly (over 10-20 minutes) with cardiac monitoring, to correct hypocalcemia and enhance myometrial contractility. 3) Prostaglandin F2α (dinoprost tromethamine): 0.1-0.25 mg/kg SC (dogs) or 0.1-0.2 mg/kg SC (cats) to stimulate uterine contraction and expulsion of retained products; use with caution as it can cause vomiting, diarrhea, and hyperthermia. 4) Antibiotics: Broad-spectrum antibiotics (e.g., amoxicillin-clavulanate 20 mg/kg PO q12h, or enrofloxacin 5-10 mg/kg PO q24h) if metritis is suspected. 5) Antifibrinolytic agents: Tranexamic acid (10-15 mg/kg IV q8h) may be considered in cases of severe hemorrhage, though evidence is limited. 6) Vitamin K1: 1-2 mg/kg SC or IM q12h if coagulopathy due to rodenticide toxicity is suspected. Surgical intervention is indicated if medical management fails, if there is uterine rupture, or if there is severe, uncontrollable hemorrhage. Ovariohysterectomy (OHE) is the definitive treatment for uterine hemorrhage, especially in cases of uterine rupture, subinvolution, or neoplasia. In cases of vaginal lacerations, surgical repair may be needed. Supportive care includes warmth, nutritional support, and monitoring of vital signs. In cases of retained fetal membranes, gentle manual removal may be attempted, but care must be taken to avoid trauma. The prognosis is good with early intervention, but guarded if shock or DIC develops.

The prognosis for postpartum hemorrhage depends on the underlying cause, severity of blood loss, and timeliness of treatment. In mild cases with prompt medical management, the prognosis is excellent, and the dam can fully recover and maintain fertility. However, in severe cases with hypovolemic shock, DIC, or uterine rupture, the prognosis is guarded to poor, with mortality rates reported up to 20-30% in severe cases. Factors that worsen the prognosis include delayed presentation, presence of coagulopathy, concurrent metritis, and the need for surgical intervention. If the dam survives, future fertility may be compromised if there is significant uterine damage or if OHE is performed. In cases of subinvolution of placental sites, the condition is usually self-limiting, and fertility is often preserved, but there is a risk of recurrence in subsequent pregnancies. If the cause is a heritable coagulopathy, the dam should not be bred again. Overall, early recognition and aggressive treatment are key to a favorable outcome.

Follow-up care for postpartum hemorrhage is essential to ensure complete recovery and monitor for complications. The dam should be re-examined within 48-72 hours after the initial episode. Serial ultrasonography should be performed weekly for 2-4 weeks to assess uterine involution and resolution of any retained products or fluid. Serum progesterone levels should be monitored to ensure they remain low (< 1 ng/mL), indicating no retained placental tissue. Vaginal cytology may be repeated to monitor for resolution of inflammation. If the dam is on antibiotics, a complete course should be administered, and a recheck culture may be indicated. The dam's PCV and total protein should be monitored to ensure recovery from anemia. If the dam is to be bred again, a breeding soundness examination should be performed after the next estrus, including vaginal cytology, progesterone assays, and ultrasonography to confirm normal uterine involution. In cases of OHE, routine postoperative care is required, including incision monitoring and pain management. The owner should be advised to monitor for any signs of recurrence, such as persistent vaginal discharge, lethargy, or inappetence. In cases of USPS, the condition may resolve spontaneously, but if bleeding persists beyond 6 weeks, further evaluation is warranted. Overall, close follow-up is crucial to prevent long-term complications.

Clinical pearls: 1) Always differentiate normal lochia from pathological hemorrhage; lochia is dark green to brown, non-clotting, and decreases over time. 2) In any postpartum dam with signs of shock, assume hemorrhage until proven otherwise and start fluid resuscitation immediately. 3) Hypocalcemia is a common contributing factor to uterine inertia; check calcium levels and administer calcium gluconate if low. 4) Oxytocin should be used cautiously; excessive doses can cause uterine tetany and rupture. 5) Ultrasonography is invaluable for assessing uterine contents and detecting retained fetal membranes or uterine rupture. 6) In cases of persistent bleeding, consider subinvolution of placental sites, especially in young bitches. 7) Always rule out coagulopathies, especially in breeds predisposed to von Willebrand disease. Pitfalls: 1) Delaying treatment while awaiting diagnostic tests can be fatal; stabilize first. 2) Administering oxytocin in the presence of uterine rupture or obstruction can worsen hemorrhage. 3) Overlooking vaginal lacerations as a source of bleeding; perform a thorough vaginal examination. 4) Assuming that bleeding is normal and not seeking veterinary attention until the dam is moribund. 5) Using non-steroidal anti-inflammatory drugs (NSAIDs) in a hypovolemic patient, which can cause renal damage. 6) Failing to monitor for DIC in cases of severe hemorrhage. 7) Not considering the possibility of retained fetal membranes, which can lead to metritis and sepsis. 8) In cats, being less vigilant due to the lower incidence, but PPH can be just as severe.

Current drug protocols for postpartum hemorrhage are based on Plumb's Veterinary Drug Handbook and theriogenology guidelines. 1) Oxytocin: Dogs: 0.5-2 IU/kg IM or IV; Cats: 0.5-1 IU/kg IM; may repeat every 30 minutes, but not more than 3 doses. 2) Calcium gluconate 10%: Dogs and cats: 0.5-1.5 mL/kg IV slowly over 10-20 minutes with ECG monitoring; can be repeated if needed. 3) Prostaglandin F2α (dinoprost tromethamine): Dogs: 0.1-0.25 mg/kg SC; Cats: 0.1-0.2 mg/kg SC; repeat every 12-24 hours as needed. 4) Cloprostenol (synthetic PGF2α): Dogs: 1-2 μg/kg SC; Cats: 1 μg/kg SC; use with caution. 5) Cabergoline (dopamine agonist): Dogs: 5 μg/kg PO q24h for 5-7 days; Cats: 5 μg/kg PO q24h for 5-7 days; used to reduce prolactin and support uterine involution. 6) Antibiotics: Amoxicillin-clavulanate: 20 mg/kg PO q12h; Enrofloxacin: 5-10 mg/kg PO q24h (use with caution in young animals); Metronidazole: 10-15 mg/kg PO q12h for anaerobic coverage. 7) Tranexamic acid: 10-15 mg/kg IV q8h (off-label). 8) Vitamin K1: 1-2 mg/kg SC or IM q12h for 3-5 days if coagulopathy is suspected. 9) Fluid therapy: Lactated Ringer's solution or Normosol-R at shock rates (90 mL/kg in dogs, 60 mL/kg in cats) initially, then maintenance (40-60 mL/kg/day). 10) Blood transfusion: Fresh whole blood or packed red blood cells at 10-20 mL/kg IV. All protocols should be tailored to the individual patient, and monitoring for adverse effects is essential.

Evidence-based literature on postpartum hemorrhage in small animals is limited, but several key studies and reviews provide guidance. A retrospective study by Smith (2005) in the Journal of Small Animal Practice reported that uterine subinvolution of placental sites was the most common cause of postpartum hemorrhage in bitches, with a good prognosis for fertility if managed conservatively. Another study by Johnston et al. (2001) in Canine and Feline Theriogenology emphasized the importance of early diagnosis and treatment of uterine inertia to prevent hemorrhage. A consensus statement from the European Society for Small Animal Reproduction (EVSSAR) recommends that any postpartum dam with signs of shock should be treated for hemorrhage immediately, with fluid resuscitation and oxytocin administration. A study by England and von Heimendahl (2010) in the BSAVA Manual of Small Animal Reproduction highlighted the role of ultrasonography in diagnosing retained fetal membranes and guiding treatment. Regarding medical management, a randomized controlled trial by Verstegen et al. (2008) compared oxytocin and prostaglandin F2α for uterine involution and found that both were effective, but prostaglandins had more side effects. A review by Plumb (2018) in the Veterinary Drug Handbook provides evidence-based dosages for oxytocin, calcium, and antibiotics. Overall, the literature supports a multimodal approach, with early intervention and surgical options reserved for refractory cases. However, large-scale prospective studies are needed to establish standardized protocols.